USFDA gives Orphan Drug Designation and Rare Paediatric Disease Designation to Aptamer developed in Hong Kong

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to S...

December 23, 2024 | Monday | News
Bio-Techne and Waters ink co-marketing agreement for biotherapeutic characterisation

American life sciences company Bio-Techne Corporation, a leader in automated platforms for biotherapeutic characterisati...

December 20, 2024 | Friday | News
Thermo Fisher introduces MagMax Sequential DNA/RNA kit to advance blood cancer research

US-based Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Sequential DNA/RNA kit to enable clinical...

December 18, 2024 | Wednesday | News
Hong Kong's Viva Biotech establishes Boston branch, marking another milestone in global expansion

Viva Biotech Holdings Group has announced the official establishment of its new branch in Boston, US. As a glo...

December 11, 2024 | Wednesday | News
Sartorius Stedim Biotech opens new centre for bioprocess innovation in Marlborough, US

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess ...

November 22, 2024 | Friday | News
Japan's Otsuka Pharma & ICU Medical sign $200 M deal to create joint venture in North America for manufacturing IV solutions

US-based ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of innovative medical devic...

November 13, 2024 | Wednesday | News
Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Another Round of Tariffs or Stumble?

With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...

November 9, 2024 | Saturday | News
EVŌQ Nano CEO Shaun Rothwell Discusses Advanced Antimicrobial Solution EVQ-218 and Its Impact on AMR

In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative potentia...

November 6, 2024 | Wednesday | News
Japan's I Peace announces new iPSC lines to reduce immune rejection risk for US population

Japan-based GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell th...

November 1, 2024 | Friday | News
Merck invests $76 M to expand ADC manufacturing for novel cancer therapies

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...

October 30, 2024 | Wednesday | News
BD and Ypsomed collaborate to advance self-injection systems for high viscosity biologics

US-based BD (Becton, Dickinson and Company) has announced a strategic collaboration with Switzerland-based Ypsomed, a le...

October 26, 2024 | Saturday | News
Agilent announces release of next-generation HPLC systems with enhanced automation and sustainability capabilities

Agilent Technologies Inc. has announced the release of its next generation Agilent InfinityLab LC Series portfolio,...

October 21, 2024 | Monday | News
Isolere Bio by Donaldson Launches Research-Grade IsoTag™ AAV Reagent for Rapid, Non-Chromatographic Viral Vector Purification

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...

October 18, 2024 | Friday | News
Hologic buys developer of minimally invasive solutions for women’s health Gynesonics for $350 M

US-based Hologic, Inc. has signed a definitive agreement to acquire Gynesonics, Inc., a medical device company focused o...

October 15, 2024 | Tuesday | News
BD announces new robotics solution to automate, standardise single-cell research

US-based BD (Becton, Dickinson and Company) has announced the commercial launch of the first in a family of high-through...

October 14, 2024 | Monday | News
Caring Cross Champions Healthcare Equity: Dr. Boro Dropulić on Reshaping CAR-T Cell Therapies Through Decentralized Manufacturing

In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...

October 14, 2024 | Monday | News
Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

October 11, 2024 | Friday | News
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis

US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_...

October 10, 2024 | Thursday | News